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Summary
A genomic library of Streptomyces cattleya was
screened to isolate a gene cluster encoding enzymes
responsible for the production of fluorine-containing
metabolites. In addition to the previously described
fluorinase FlA which catalyzes the formation of 50-
fluoro-50-deoxyadenosine fromS-adenosylmethionine
and fluoride, 11 other putative open reading frames
have been identified. Three of the proteins encoded
by these genes have been characterized. FlB was
determined to be the second enzyme in the pathway,
catalyzing the phosphorolytic cleavage of 50-fluoro-
50-deoxyadenosine to produce 5-fluoro-5-deoxy-D-
ribose-1-phosphate. The enzyme FlI was found to be
an S-adenosylhomocysteine hydrolase, which may
act to relieve S-adenosylhomocysteine inhibition of
the fluorinase. Finally, flK encodes a thioesterase
which catalyzes the selective breakdown of fluoroace-
tyl-CoA but not acetyl-CoA, suggesting that it provides
the producing strain with a mechanism for resistance
to fluoroacetate.
Introduction
Fluorine is the 13th commonest element in the earth’s
crust [1]. Despite the element’s natural abundance, or-
ganically bound fluorine is relatively rare in nature. This
contrasts markedly with the wide diversity of chlorine-
containing natural products [2]. The apparent discrep-
ancy between the natural abundance of fluorine and the
rarity of naturally occurring organofluorine compounds
can be explained by two principal considerations: first,
the low solubility of mineral fluorine means that only
a small fraction of the total mineral fluoride is available
to organisms. Sea water, for example, contains only
*Correspondence: jbs20@cam.ac.uk1.3 ppm of fluoride in contrast to 19,000 ppm of chloride.
Second, the high redox potential required for the oxida-
tion of fluoride probably prevents it from being activated
through a similar mechanism to that used by enzymes
to effect chlorination. It is proposed that both haloper-
oxidases and halogenases generate HOCl as the active
chlorinating species, thus explaining why these enzymes
do not take fluoride [3, 4].
The most widespread known fluorinated natural prod-
uct is fluoroacetate and it is found, often in high concen-
trations, in the leaves and seeds of a variety of tropical
plants [5]. Despite considerable interest and effort, little
progress has been made in understanding the process
of fluorination in higher plants [6]. A suitable bacterial
system offers a more accessible route of investigation.
The production of fluorometabolites by bacterial spe-
cies is particularly unusual despite the great diversity
of bacterial natural products. Only two bacterial strains,
both actinomycetes, have been identified with the ability
to synthesize organofluorine compounds. Nucleocidin
was originally isolated from Streptomyces calvus in
1956 [7]. More recent attempts to isolate the compound
from this species have failed and hence prevented in-
vestigation of the biosynthetic route to this interesting
natural product. The discovery in 1986 that Streptomy-
ces cattleya was capable of producing both fluoroace-
tate (5) and 4-fluorothreonine (6) [8] provided an alterna-
tive system for the study of the mechanism of biological
fluorination. The biosynthetic route to these fluorinated
metabolites has been investigated by the feeding of
13C- and 2H-enriched precursors. Such studies have
identified fluoroacetaldehyde (4) as a key common inter-
mediate in the biosynthesis of both fluoroacetate (5) and
4-fluorothreonine (6) [8–12]. A PLP-dependent threonine
transaldolase activity was subsequently purified from
cell-free extracts of S. cattleya that was able to convert
fluoroacetaldehyde (4) into 4-fluorothreonine (6) [13].
Similarly, an NAD+-dependent fluoroacetaldehyde de-
hydrogenase capable of oxidizing fluoroacetaldehyde
(4) to fluoroacetate (5) was purified from the same strain
[14]. More recently, the key fluorination enzyme FlA was
identified and shown to catalyze the initial fluorination
of S-adenosylmethionine (SAM) (1) to give 50-fluoro-50-
deoxyadenosine (50-FDA) (2) [15]. The crystal structure
of this enzyme has been determined [16]. 50-FDA has
thus been identified as the first fluorinated organic
compound in the pathway to fluoroacetaldehyde (4).
Very recently, 5-fluoro-5-deoxy-D-ribose-1-phosphate
(5-FDRP) (3) has been proposed as the next intermedi-
ate of the pathway [17] (Figure 1). A nucleoside phos-
phorylase activity has been identified and partially puri-
fied from cell-free extracts of S. cattleya which is able to
displace the nucleotide base from 50-FDA (2) with phos-
phate to give 5-FDRP (3). Incubation of 5-FDRP (3) with a
cell-free extract ofS. cattleya resulted in the formation of
fluoroacetate (5) [17]. However, the steps from 5-FDRP
(3) to fluoroacetaldehyde (4) remain to be elucidated.
In this study, we report the cloning and sequence anal-
ysis of a locus containing genes clustered around the
previously identified fluorinase gene flA from a genomic
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acetate (5) and 4-Fluorothreonine (6)DNA cosmid library isolated fromS. cattleya. These genes
are therefore likely to be involved in fluorometabolite
biosynthesis in this organism. Of particular interest is
the characterization of three genes: the flB gene encod-
ing the 50-FDA (2) phosphorylase responsible for conver-
sion of 50-FDA (2) into adenine and 5-FDRP (3), FlI encod-
ing an adenosylhomocysteine lyase proposed to relieve
S-adenosylhomocysteine inhibition of the fluorinase, and
a resistance gene, flK, for the specific degradation of
fluoroacetyl-coenzyme A (fluoroacetyl-CoA) into fluo-
roacetate and coenzyme A (CoA).
Results and Discussion
Cloning of the fl Locus
A genomic library of S. cattleya was constructed in
SuperCos 1 vector (Stratagene). This was screened by
a PCR-based method with perfectly matched primers
that hybridize to regions of the flA gene. One cosmid
clone designated SC8E11 was isolated that gave PCR
products of the expected size under conditions of high
stringency for binding of the oligonucleotides to the cos-
mid template. A large-scale cosmid preparation was
obtained. This was directly sequenced with the oligonu-
cleotide primers used in the PCR screening reaction and
the presence of the flA gene was confirmed by compar-
ison of the sequence thus identified from the cosmid
clone and published flA sequence [16]. The DNA se-
quence of SC8E11 (encoding a 34 kbp insert) was ob-
tained in its entirety. Analysis of the DNA sequence of
this clone showed it to encode several genes clustered
around the fluorinase gene that are thought to be in-
volved in fluorometabolite biosynthesis. These geneshave been designated fl gene locus (Figure 2) and
deposited in the EMBL nucleotide sequence database
(accession number: AM055586).
Organization of the fl Locus
The genes of the fl locus are clustered in the middle of
the insert of SC8E11 cosmid, and the flA gene located
in the center of the locus encodes the previously charac-
terized fluorinase FlA [18]. The limits of thefl locus remain
to be determined by gene disruption experiments, so
the contribution of the 12 identified open reading frames
remains speculative. Clear housekeeping functions can
be assigned to genes flanking this locus: a diaminopime-
late decarboxylase (EC 4.1.1.20 lysine biosynthesis) and
an arginyl-tRNA synthetase (EC 6.1.1.19 arginyl-tRNA
biosynthesis) are found right upstream of the fl cluster.
Genes identified downstream of the fl cluster are 1,4-a-
glucan branching enzyme (EC 2.4.1.18 starch and sucrose
metabolism), D-amino acid oxidase (EC 1.4.3.3 amino
acid metabolism), and a cell cycle protein.
Biosynthesis of 5-Fluoro-5-Deoxy-D -Ribose-1-
Phosphate
Immediately upstream of flA is a putative open reading
frame (flB) that is divergently transcribed and predicted
to encode a protein of 299 amino acids having a high
degree of end-to-end similarity to authentic nucleoside
phosphorylases. Our in vitro assays (see below) have
demonstrated that the flB gene product catalyzed the
phosphorolytic conversion of 50-FDA (2) to adenine and
5-FDRP (3), which is in agreement with a recent study
carried out by using a cell-free extract from S. cattleya
[17]. FlB was overexpressed in Escherichia coli as aFigure 2. Map of the fl Gene Locus and Pos-
sible Functions for the Proteins Encoded by
the Open Reading Frames
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477His-tagged protein and purified with His-Bind metal che-
lating resin (Novagen). From 1 liter of culture about 1 mg
of purified FlB was obtained. The low yield is mainly due
to the insolubility of the majority of the overexpressed
protein. Purified FlB appeared on SDS-PAGE as an
w35 kDa protein (Figure 3).
The molecular weight of the protein determined by
LC-ESI-MS is 33,644, which is consistent with the calcu-
lated value of 33,645. The peak at 33,822 represents the
mass of the protein with an N-terminal gluconoylation
(M+178) generated by E. coli [19]. Enzymatic assays
have demonstrated that FlB is a nucleotide phosphory-
lase catalyzing the phosphate-dependent cleavage of
50-FDA (2) to yield adenine and 5-FDRP (3). The genera-
tion of adenine was monitored by HPLC with UV and
MS detection and comparison of the retention time of
the generated adenine with an authentic reference (Fig-
ure 4A). The formation of the 5-FDRP (3) was confirmed
with 19F-NMR and 1H-NMR (Figures 4B and 4C). In the
19F-NMR, a new signal at 2231.02 ppm is observed in
the FlB enzyme assay just beside the signal for 50-FDA
Figure 3. SDS-PAGE of FlB
Lane 1: purified recombinant FlB. Lane 2: protein molecular weight
marker (MBI Fermentas); ESI-MS of FlB.(2) at 2230.78 ppm, indicating the generation of a new
fluororibose derivative. Furthermore, in the 1H-NMR, a
characteristic doublet of doublets coupling pattern for
the anomeric proton of 3 at 5.69 ppm clearly indicates
the attachment of the phosphate. This signal pattern
matches that of the commercially available ribose-1-
phosphate. The signals for H-C2, H-C3, and H-C4 of
fluororibose-1-phosphate could also be observed clearly
in thebioassay. However,bothsignals for H-C5arehidden
in the solvent signal.
Additionally, we performed an assay with FlB in the
presence of adenosine. The 1H-NMR of the ribose-1-
phosphate generated closely matched that of the com-
mercially available standard.
The formation of two new signals at 8.20 and 8.24 ppm
in the aromatic region provides further evidence for the
formation of adenine by using either 50-FDA (2) or aden-
osine as a substrate for FlB. The combination of our MS
and NMR data clearly indicates the production of 5-
FDRP (3) even though the signals for H-C5 are obscured.
The purified recombinant FlB exhibited a Km of 35 mM
for 50-FDA and a Vmax of 15 mmol/min/mg protein (see
Supplemental Data available with this article online).
No 50-FDA (2) cleavage was observed in the experiments
with pyrophosphate instead of phosphate, confirming
the requirement of phosphate ions for the enzyme activ-
ity. Adenosine is determined to be a poor substrate for
FlB. At a substrate concentration of 60 mM in a 100 ml re-
action, detection of adenine formation from adenosine
in the presence of 100 ng of FlB required 30 min incuba-
tion at 30ºC (data not shown). Under the same assay
conditions, however, 40 ng of FlB catalyzed the release
of similar amounts of adenine from 50-FDA within 1 min,
demonstrating that the enzyme is selective for the fluo-
rinated substrate.
Transmembrane Transport of Ions
and Fluorometabolites
Two open reading frames within the fl locus are pre-
dicted to encode proteins that act as transmembraneFigure 4. Characterization of FlB Activity by
LC-ESI-MS, 19F-NMR, and 1H-NMR
(A) LC-MS trace of the formation of adenine
by FlB.
(B and C) 19F-NMR (B) and 1H-NMR (C) after
incubation of FlB with 50-fluoro-50-deoxyade-
nosine (50-FDA, 2), indicating the formation
of FDRP (3).
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with high similarity to transmembrane Na+/H+ antipor-
ters. Na+/H+ exchange proteins eject protons from cells,
effectively eliminating excess acid from actively metab-
olizing cells. Na+/H+ exchange activity is crucial for the
regulation of cell volume and for the reabsorption of so-
dium chloride across renal, intestinal, and other epithelia
[20]. The movement of fluoride ions across the cell mem-
brane is thought to be as the un-ionized HF. Erythrocytes
incubated in the presence of sodium fluoride accumulate
fluoride anions in association with a decrease in intracel-
lular pH [21]. It has been observed in a study on fluorome-
tabolite production in resting cells of S. cattleya that the
fluoride uptake was maximal at pH 6.0 and sharply de-
clined at higher pH [10], indicating that a certain level of
extracellular H+ was required for transport of F2 into
cells. FlH may therefore function as a Na+/H+ antiporter
that buffers the accumulation of HF by exchange of an
intracellular proton for an extracellular sodium ion and
results in restoration of intracellular pH and net intracel-
lular accumulation of NaF. The inferred translation prod-
uct of flC is a 397 amino acid protein with significant
sequence similarity to members of the MFS transporter
family [22, 23]. These proteins are responsible for the
transport of small metabolites across the cell membrane.
The role of FlC remains to be established but it may be
a candidate for the transmembrane transport of fluoro-
acetate (5) and/or 4-fluorothreonine (6).
Resistance
The deduced protein product of flD (216 amino acids)
shows similarity to a number of haloacid-dehalogenase
[24] (EC 3.8.1.2) and phosphatase/phosphomutase (EC
3.1.3.18) enzymes. flD could encode a resistance mech-
anism that is able to defluorinate fluoroacetate (5) and/or
4-fluorothreonine (6) acting as a resistance and regula-
tory gene product. It is also possible, however, that FlD
may play a role in further metabolism of 5-FDRP (3) in
the pathway leading to fluoroacetate (5).
The small protein (139 amino acids) encoded by the flK
gene is a putative thioesterase as suggested by a BLAST
search against the NCBI conserved domain database.
FlK shows end-to-end homology (26%–54% of identity)
to many predicted thioesterases or hypothetical proteins
in bacteria, including an extremely halotolerant and
alkaliphilic deep sea strain, Oceanobacillus iheyensis
HTE831, and several thermophilic bacteria. FlK homo-
logs with unknown functions are also found in a couple
of thermo/acidophilic archaea as well as in eukaryotic
organisms such as Dictyostelium discoideum and Tet-
raodon nigroviridis. The majority of FlK homologs have
protein sizes similar to FlK, ranging between 127 and
180 amino acids. A protein sequence alignment of FlK
with representative homologs is shown in Figure 5. Nine
amino acid residues, Gly8, Thr42, Glu50, Leu61, Gly69,
His76, Ala78, Gly83, and Gly116, in FlK appear to be
well conserved in all these homologs. From this we spec-
ulate that FlK employs a variation of the classical cata-
lytic triad-type mechanism [25] with Thr42 (instead of
Ser), Glu50 (instead of Asp), and His76. Although prote-
ases employing threonine instead of serine as part of
the catalytic triad are known [26], there are no examples
of thioesterases to our knowledge that utilize threonine
in this role. It is tempting to speculate that having asecondary alcohol as the nucleophile might partly ex-
plain the exquisite selectivity shown by this enzyme.
To determine the function of FlK as a thioesterase, FlK
protein was overexpressed in E. coli as a His-tagged
protein and purified with His-Bind metal chelating resin
(Novagen). The yield of the overexpressed recombinant
FlK was about 10 mg per liter of culture. Purified FlK
gave a band on SDS-PAGE with a molecular weight
slightly less than 18 kDa (Figure 6A). The molecular
weight of the FlK protein determined by LC-ESI-MS is
17,287 Da, in good agreement with the calculated mo-
lecular mass (17,288 Da) of the recombinant FlK without
the first methionine residue that is often removed after
expression of the protein by E. coli. Fluoroacetyl-CoA,
the substrate used in the in vitro FlK enzymatic assays,
was synthesized by activation of fluoroacetate sodium
salt with oxalylchloride and DMF and subsequent reac-
tion with coenzyme A. Fluoroacetyl-CoA slowly decom-
poses at 25ºC and pH 8.0 as previously reported [27].
Therefore, the reaction rates for FlK have been cor-
rected for the nonenzymatic hydrolysis of the substrate.
The breakdown of fluoroacetyl-CoA to coenzyme A
and fluoroacetate by FlK was followed by monitoring
the UV signal at 412 nm of the generated coenzyme A
after reaction with 5,50-dithiobis-2-nitrobenzoic acid
(DTNB) [28]. The formation of fluoroacetate by FlK was
verified by direct observation of the 19F-NMR fluoroace-
tate signal during the FlK assay (Figure 6C).
The purified recombinant FlK catalyzed the hydrolysis
of fluoroacetyl-CoA with a Km of 30 mM and a Vmax of
15 mmol/min/mg protein (Figure 6B) but did not exhibit
any activity toward acetyl-CoA at a concentration up
to 1 mM. The observed high selectivity of the enzyme
further supports its function as a resistance mechanism.
The Km and Vmax values of FlK are similar to those of an
acetyl-CoA hydrolase isolated from pig heart, which
Figure 5. Multiple Protein Sequence Alignment of FlK with Related
Proteins
The conserved Thr42, Glu50, and His76 are suggested to constitute
a catalytic triad mechanism (highlighted by arrows).
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(A) SDS-PAGE of FlK. Lane 1: purified recombinant FlK. Lane 2: protein molecular weight markers (MBI Fermentas).
(B) Lineweaver-Burk plot of fluoroacetyl-CoA hydrolysis catalyzed by FlK. v, initial rate of CoASH release (mM/min); [S], fluoroacetyl-CoA con-
centration (mM).
(C) 19F-NMR monitoring of the formation of fluoroacetate by FlK catalyzing the hydrolysis of fluoroacetyl-CoA.exhibited a Km of 48 mM and a Vmax of 2.7 mmol/min/mg
protein [29]. Long-chain fatty acid CoAs are the sub-
strate of most of the characterized acyl-CoA hydrolases
deposited in the enzyme database BRENDA. These hy-
drolases exhibit Km values in a range from 1 mM to 50 mM
and a Vmax less than 5 mmol/min/mg protein.
Fluoroacetyl-CoA hydrolase-like activity has been ob-
served in a crude mitochondrial enzyme extract from the
plant Dichapetalum cymosum [27]. It has been shown
that fluoroacetyl-CoA is a substrate for citrate synthase
and reacts with oxalacetate to produce 2-fluorocitrate
[30–32]. Lauble et al. presented experimental evidence
indicating that the (2)-erythro diastereomer of 2-fluoro-
citrate can be further converted to 4-hydroxy-trans-
aconitate, a strong competitive inhibitor of aconitase,
thereby blocking the tricarboxylic acid cycle [33]. Both
in vivo and in vitro synthesis of fluoroacetyl-CoA from
fluoroacetate by acetyl-CoA synthetase has been re-
ported [34, 35]. The presence of a fluoroacetyl-CoA-spe-
cific thioesterase in fluoroacetate-producing S. cattleya
is significant in that it provides an effective self-defense
mechanism to prevent any fluoroacetyl-CoA formed
from entering the tricarboxylic acid cycle.
Regulatory and Other Genes
flI encodes a putative protein of 489 amino acids and
shows a very high overall sequence homology toS-aden-
osyl-L-homocysteine hydrolase (AdoHcyase), which
catalyzes reversible hydrolysis of S-adenosyl-L-homo-
cysteine (AdoHcy) into homocysteine and adenosine
(Figure 7B). We heterologously expressed and purified
FlI (Figure 7A) in order to investigate this hypothesis.
The enzyme does indeed hydrolyze AdoHcy (forwardreaction) and is also capable of catalyzing AdoHcy for-
mation if supplied with homocysteine and adenosine
(reverse reaction; Figure 7).
It has been previously demonstrated that AdoHcy is
a competitive inhibitor of FlA [36]. In our study, the pro-
duction of 50-FDA from SAM catalyzed by purified FlA
decreased more than 85% in the presence of AdoHcy
at a 5 to 1 molar ratio of substrate to inhibitor (Supple-
mental Data). FlI might therefore promote 50-FDA (2) bio-
synthesis by limiting the concentration of this inhibitor
in the cells. Km and Vmax for FlI-catalyzed hydrolysis of
AdoHcy have been determined to be 174.5 mM and 189
mmol/min/mg protein, respectively (Supplemental Data).
These values are much higher than those for similar en-
zymes from other sources. We speculate that at a normal
physiological concentration of AdoHcy, FlI may work at
its minimum velocity without disturbing primary metab-
olism and only functions efficiently when there is extra
AdoHcy present. Additionally, FlI-catalyzed AdoHcy
hydrolysis was inhibited significantly (more than 95%)
by SAM at an AdoHcy:SAM molar ratio of 67:1 (Supple-
mental Data). Intermediate inhibition of AdoHcy hydro-
lase activity by SAM has been previously reported [37].
The crossinhibition of FlA and FlI by each other’s sub-
strates indicates a possible role played by both SAM
and AdoHcy in fine-tuning of the activities of these
enzymes.
The predicted product of flJ is similar to a family of
proteins of unknown function. A possible regulatory
role for this gene is suggested by the presence of the
rare TTA codon encoding leucine at amino acid position
43. A+T-rich codons are rarely used in high-G+C-con-
taining Streptomyces DNA. TTA codons have been
Chemistry & Biology
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(A) SDS-PAGE of FlI. Lane 1: purified recombinant FlI. Lane 2: protein molecular weight marker (MBI Fermentas).
(B) Reaction catalyzed by the S-adenosylhomocysteine hydrolase FlI.
(C) LC-MS ion traces and ESI-MS of S-adenosylhomocysteine and adenosine generated by FlI.found in many Streptomyces genes expressed in late
growth phase but not in genes known to be required
for primary metabolism. These late-expressing genes
include antibiotic pathway-specific genes, antibiotic re-
sistance and biosynthesis genes, sporulation genes,
and many genes with unknown function [38]. Studies
on Streptomyces coelicolor mutants deficient in the for-
mation of aerial mycelium have identified several un-
linked bld genes. Mutants specifically deficient in the
bldA gene fail to produce aerial mycelium and antibi-
otics. The product of the bldA locus is a tRNA molecule
which recognizes and translates the rare TTA codon for
leucine [39]. The accumulation of the mature bldA tRNA
has also been shown to be growth phase dependent
and reaches maximal level late in growth. This may facil-
itate integrated control of differentiation and secondary
metabolism by ensuring that key genes contain such
a codon and are expressed only at later stages of the
life cycle.
The fl locus contains four genes predicted to encode
helix-turn-helix DNA binding proteins [40]: flE (222 amino
acids), flF (185 amino acids), flG (234 amino acids), and
flL (225 amino acids). They are likely to be involved in
transcriptional control of open reading frames of the fl
locus.
As mentioned earlier, the activities responsible for the
late steps in fluorometabolite biosynthesis, such as the
conversion of fluoroacetaldehyde (4) to 4-fluorothreo-
nine (6) and its oxidation to fluoroacetate (5), have previ-
ously been identified in partially purified enzyme prepa-
rations ofS. cattleya [11, 13, 14, 41]. The genes encoding
these enzymes, however, do not appear to be present
within the fl cluster. Further experiments are needed to
investigate whether there is a second locus that con-
tains these missing genes or whether enzymes catalyz-
ing similar reactions in primary metabolism may accept
fluorinated substrates.Significance
The cloning and analysis of the first gene cluster in-
volved in organofluoro compound formation (fl) are
presented. Twelve open reading frames with possible
roles in biosynthesis of fluorometabolites have been
identified around the previously characterized fluori-
nase gene (flA) of Streptomyces cattleya. One open
reading frame designated flB has been shown to en-
code the nucleoside phosphorylase activity that con-
verts 50-fluoro-50-deoxyadenosine, the first fluorinated
intermediate produced by FlA, into 5-fluoro-5-deoxy-
D-ribose-1-phosphate. FlI has been determined to be
an S-adenosylhomocysteine hydrolase, suggesting
that this enzyme is necessary for the fluorinase to be
fully active, as adenosylhomocysteine has been shown
to be a potent inhibitor of this enzyme. Of particular in-
terest is the presence of the flK gene, shown to encode
a fluoroacetyl-CoA-specific thioesterase. The expres-
sion of FlK ensures that when fluoroacetyl-CoA is
formed by the producing strain it is then immediately
degraded before it can be further metabolized to pro-
duce 4-hydroxy-trans-aconitate, a lethal inhibitor of
the tricarboxylic acid cycle.
Experimental Procedures
Strains, Culture Conditions, and Plasmids
Streptomyces cattleya was propagated in a defined medium for
S. cattleya [10] at 30ºC. SuperCos 1 (Stratagene) was used as the
vector for construction of the genomic DNA library. Library transfec-
tions were performed in Escherichia coli XL-1 Blue MR (Stratagene).
Recombinant cosmids were subcloned in pSHG397 [42] and re-
combinants were selected by chloramphenicol. Plasmids were ma-
nipulated in E. coli DH10B (GIBCO-BRL) by using standard proto-
cols [43]. pET28a(+) was used as the vector for protein expression
in E. coli BL21 (DE3) (Novagen). All procedures were carried out
according to manufacturers’ recommendations.
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Total DNA was isolated from S. cattleya by procedure B of Kieser
et al. [44]. For the generation of the cosmid library, total DNA was
partially digested with BamHI, dephosphorylated with shrimp intes-
tinal alkaline phosphatase, and ligated directly into SuperCos 1 and
packaged with Gigapack Gold packaging extract (Stratagene) with-
out size fractionation. All procedures were done in accordance with
the manufacturer’s recommendations (Stratagene).
Screening of the S. cattleya library was performed by a PCR-
based methodology. Briefly, 960 colonies of the S. cattleya cosmid
library were grown in 1 ml twice-strength LB (23 LB containing 50
mg kamamycin and 100 mg ampicillin) cultures on 96-well plates for
24 hr at 37ºC. Fifty microliters of each culture was transferred to
a 96-well microtiter plate by a multichannel pipette and stored at
280ºC with an equal volume of 80% glycerol (40% final). Small-scale
DNA preparations (High Yield Protocol 1, Plasmid Minipreparation
with MultiScreen, Millipore) were made from the remaining 900 ml
of each culture and resuspended in 100 ml sterile water. This pro-
vided ten 96-well plates with 100 ml suspended DNA in each well
that could be easily crossreferenced to an equivalent sample of cells
stored in ten corresponding 96-well plates at280ºC. To simplify the
PCR screen, 1 ml DNA was transferred from each corresponding
position on the 96-well plate to a single master plate, so that position
A1 of the master plate contained 1 ml DNA from position A1 of each of
the ten microtiter plates. This plate was then screened by PCR with
oligonucleotides designed internal to the published sequence of the
flA gene, designated pSCF2 50-GAG GAG CAC GGC TAC CTG GAG
GCG TAC GAG GTC ACC TCG-30, pSCF5 50-GCC AAG GGC GGT
GCC CGC GGC CAG TGG GCG-30, and pSCF10 50-TGG TCG ATG
GCG GAG ACC ACG CCC ACC AGC-30. PCR reactions were per-
formed in 50 ml final volumes with a final concentration of 2%
DMSO and Biomix Red PCR premix (Bioline). PCR conditions were
preheating at 94ºC for 10 min, followed by 30 cycles of denaturation
at 94ºC for 1 min, annealing at 60ºC for 1 min and extension at 72ºC
for 1 min, with a final 10 min infilling at 72ºC. Expected PCR product
sizes of 239 bp and 350 bp were observed for three wells. All ten
samples that had contributed DNA to these three wells were then re-
screened by the above protocol. Three cosmids were thus identified
as giving an appropriate PCR product size of 350 bp, namely SC5H2,
SC8E11, and SC8H9. The stored replica deep plates were used to in-
oculate cultures with each of the above cosmid clones. Cosmid DNA
for sequencing was prepared by using the Qiagen Midi-prep DNA
purification kit from liquid cultures (50 ml) in 23 LB medium with ap-
propriate antibiotic selection. The presence of the flAgene sequence
in all three cosmids was further confirmed by direct sequencing of
the cosmid DNA with pSCF5 and pSCF10 primers that identified
the expected flA sequences.
One cosmid SC8E11 was sequenced in its entirety. Sequence
data were obtained from assembly of overlapping Sau3AI fragments
acquired from partial digestion of the parent cosmid. The 2–5 kbp
fraction of the digest was eluted from an agarose gel by using the
QIAEX II gel extraction kit (Qiagen) and subcloned into pSHG397
[42]. The entire sequence of the SC8E11 clone was determined
from forward and reverse primary sequences of 192 templates
with gaps filled by oligonucleotide-directed sequencing.
DNA Sequencing
All sequencing was performed in the Department of Biochemistry
DNA Sequencing Facility, University of Cambridge. An Applied Bio-
systems 800 molecular biology CATALYST robot was used to apply
Taq dideoxy terminator sequencing reactions (Big Dye Terminator
kit, Applied Biosystems) to an ABI 373A sequencer according to
the manufacturer’s protocol. End sequencing of cosmids used T3
and T7 primers. Plasmid sequencing used pUC forward and reverse
primers. SeqEd v 1.0.3 was used for sequence editing. Database
searches used the BLAST algorithm. Sequence assembly employed
the GAP (genome assembly program), version 4.2 [45].
Expression and Purification of FlB, FlK, and FlI
The flB, flK, and flI genes were amplified by PCR utilizing cosmid
SC8E11 as a template. The following oligonucleotides were used
as primers in the PCR reactions: pSCphos1 50-CCG GAG GTG
CGC ATA TGC GGG CAC GGA AAT-30 and pSCphos2 50-GGG TAC
CGG AGG GAT CCG GGC CCC GCG CTG-30 for flB, pflK-3 50-AGTGAG GAG TGG CAT ATG AAG GAC GGC ATG-30 and pflK-2 50-
GCG GAT CCC GCC GGA GAA CCT GAT CGT GCT-30 for flK, and
pflI-1 50-GCA GTC GAA GGC GCT AGC ATG GCA GTC GTA-30 and
pflI-2 50-GCT TCC ATC TCG AGC GTG CCC CCT CAG TAT-30 for
flI. To facilitate cloning, restriction sites were engineered at the 50
primer/30 primer: NdeI/XhoI for flB, NdeI/BamHI for flK, and NheI/
XhoI for flI, as indicated by the underlining. PCR was carried out
with Pfu DNA polymerase with 25 cycles of denaturing at 94ºC for
1 min, annealing at 55ºC for 1 min, and extension at 72ºC for 1 min
plus a final extension at 72ºC for 10 min. The PCR products were di-
gested with appropriate restriction enzymes, purified by gel extrac-
tion (Qiagen), and inserted into a pET28a(+) plasmid. The inserts
of the recombinant plasmids were verified by DNA sequencing.
The recombinant plasmids were introduced into E. coli Rosetta
(DE3)pLysS-competent cells (Novagen). An overnight culture (10
ml) from a single colony of the transformants was used for inocula-
tion of 1 liter of fresh LB medium containing kanamycin (50 mg/ml).
The culture was incubated at 37ºC until OD600 = 0.5–0.8 was
reached. Overexpression of the proteins was induced by isopro-
pylthiogalactoside (0.2 mM) overnight at 16ºC with shaking at 220
rpm. Cells were harvested by centrifugation and the overexpressed
recombinant protein was released by sonication for 4 min (1 s on, 10
s off). The supernatant of the cell lysate was allowed to pass through
a column of Co2+ ion-charged His-Bind metal chelating resin (Nova-
gen). Nonspecific proteins were removed by washing the column
with washing buffer (0.5 M NaCl, 5–60 mM imidazole, 20 mM Tris-
HCl [pH 7.9]) and the recombinant protein was eluted with elution
buffer (0.5 M NaCl, 200 mM imidazole, 20 mM Tris-HCl [pH 7.9]).
The purified proteins were stored at 4ºC in a buffer containing 200
mM KCl and 20 mM Tris-HCl (pH 7.5). Enzymes used for kinetic stud-
ies were further purified by gel filtration on an A¨KTA Explorer FPLC
system with a HiLoad 16/60 Superdex 200 Prep Grade column and
a mobile phase containing 200 mM KCl and 20 mM Tris-HCl (pH
7.5). The protein concentrations were determined by using Bradford
protein dye reagent (Sigma).
Assay of FlB
A typical reaction for FlB activity assay contained 50-FDA (2) (1 mM
[17], KH2PO4 [2.5 mM, adjusted to pH 7.5 with 5 M KOH]), purified
FlB (40 mg) in 100 ml HEPES buffer (50 mM, pH 7.5). Control reactions
were carried out in the absence of either FlB or 50-FDA (2) or KH2PO4.
The reaction mixture was incubated at 37ºC for 60 min and termi-
nated by the addition of chloroform (100 ml). Protein precipitate
was removed by centrifugation. The supernatant was analyzed by
HPLC, LC-MS, and 1H- and 19F-NMR.
For the LC-MS experiments, a ThermoFinnigan LCQ fitted with
an ESI source connected to an Agilent HP 1100 HPLC system
was used. One hundred microliter samples were injected onto a
Phenomenex Synergy polar RP18 column (125 mm 3 2 mm, 4 mm;
Phenomenex, Macclesfield Cheshire, UK) and separated by gra-
dient elution. HPLC conditions: 100% A for 5 min, gradient to
100% B in 35 min, 100% B for 5 min; A: H2O 0.1% TFA, B: CH3CN
0.1% TFA; flow rate 0.3 ml/min. The ESI-MS and retention time
of the product of the FlB reaction adenine was verified with an
authentic standard.
50-fluoro-50-deoxyadenosine (50-FDA, 2) ESI-MS: [M+H]+ 270
(100), 136 (38); retention time: 9.7 min.
Adenosine ESI-MS: [M+H]+ 268 (100), 136 (63); retention time:
4.3 min.
Adenine ESI-MS: [M+H]+ 136 (100); retention time: 3.7 min.
For the 19F-NMR experiments, the assay was upscaled by using
50-FDA (1 mM), KH2PO4 (2.5 mM, adjusted to pH 7.5 with 5 M
KOH), purified FlB (500 mg) in 500 ml HEPES buffer (50 mM, pH 7.5).
After 1 hr reaction time, 19F-NMR experiments were performed di-
rectly after addition of 100 ml D2O to the aqueous reaction mixture
on a Bruker Avance 400 MHz NMR spectrometer by using CCl3F
for calibration.
50-fluoro-50-deoxyadenosine (50-FDA) (2): 19F-NMR (380 MHz,
D2O/H2O, ppm): d 2230.78.
5-fluoro-5-deoxy-ribose-1-phosphate (3): 19F-NMR (380 MHz,
D2O/H2O, ppm): d 2231.02.
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tions: 50-FDA or adenosine (1 mM), KH2PO4 (2.5 mM, adjusted to pH
7.5 with 5 M KOH), purified FlB (500 mg) in 3 ml 20 mM Tris (pH 7.2).
After incubation for 1 hr, the reaction was quenched by precipitation
of the enzyme. One tenth of a milliliter of chloroform was added, and
the mixture was vortexed for 1 min and centrifuged for 2 min. The
supernatant was collected and the precipitation procedure was re-
peated twice. The aqueous supernatant was freeze dried. The sam-
ple was dissolved in 500 ml D2O and analyzed by using a Bruker
Avance 500 MHz spectrometer fitted with a TCI cryoprobe. Chemical
shifts of 1H-NMR spectra are given in ppm (d) based on the solvent
signal: D2O 4.67 ppm.
a-5-fluoro-5-deoxy-ribose-1-phosphate (3): 1H-NMR (500 MHz,
D2O, ppm): d 4.10–4.13 (m, 1H, H-C2), 4.14–4.16 (m, 1H, H-C3),
4.31–4.38 (m, 1H, H-C4), 5.69 (dd, J = 6.7, J = 3.8, 1H, H-C1).
Adenine: 1H-NMR (500 MHz, D2O/HEPES buffer, ppm): 8.20 (s,
1H), 8.24 (s, 1H).
Ribose-1-phosphate: 1H-NMR (500 MHz, D2O/HEPES buffer,
ppm): d 3.57–3.74 (m, 2H, H-C5), 4.05 (dd, J = 6.3, J = 4.1, 1H,
H-C3), 4.10–4.13 (m, 1H, H-C2), 4.22 (dd, J = 8.3, J = 3.4, 1H,
H-C4), 5.62 (dd, J = 6.4, J = 4.1, 1H, H-C1). The generation of
ribose-1-phosphate was compared to an authentic reference.
For the kinetic study of FlB activity, 40 ng FlB was incubated in 500
ml Tris-HCl (50 mM, pH 7.5) buffer at 30ºC with 50-FDA at concentra-
tions of 40, 50, and 60 mM. A 100 ml aliquot of each reaction was taken
out after 1, 2, 3, 4, and 5 min incubation and vortexed immediately
with an equal volume of chloroform to precipitate the enzyme. The
reactions were analyzed by HPLC with an XTerra RP18 column
(4.6 3 250 mm, 5 mm) with a mobile phase of 0%–15% acetonitrile
over 25 min on an Agilent HP 1100 HPLC system. The abundance
of adenine formed was quantified based on the absorbance of ade-
nine at 254 nm wavelength. Data points are the mean value of three
replicates. An authentic adenine standard (Sigma) was used for the
standard curve.
Synthesis of Fluoroacetyl-CoA
To 100 mg (1 mmol) fluoroacetate sodium salt in 2 ml dry THF, 100 ml
DMF and 1 mmol oxalylchloride (2 M CH2Cl2 solution) were added
dropwise. The solution was stirred under reflux for 6 hr. After cool-
ing, one quarter (0.25 mmol) of the solution was added quickly under
rigorous stirring to 50 mg (0.06 mmol) coenzyme A lithium salt dis-
solved in 1 ml 10% NaHCO3. After 5 min of stirring, the reaction
was completed. THF was removed in a gentle stream of nitrogen
and the crude fluoroacetyl-CoA was immediately purified by RP18
HPLC (A: H2O, B: MeOH; 100% A to 100% B in 30 min; flow rate 10
ml/min; Phenomenex Luna 2503 20 mm, 10 mm) in order to prevent
degradation of fluoroacetyl-CoA. Fractions containing fluoroacetyl-
CoA were combined after verification by ESI-MS injection. MeCN
was removed in vacuo and the sample was lyophilized.
Yield: 35 mg, 71%.
1H-NMR (500 MHz, D2O, ppm): d 0.69 (s, 3H), 0.79 (s, 3H), 2.31 (t,
J = 6.4, 2H), 2.95 (t, J = 6.36, 2H), 3.23 (t, J = 6.3, 2H), 3.32 (t, J =
6.8, 2H), 3.51 (dd, J = 9.67, J = 4.22, 1H), 3.73 (dd, J = 9.67, J =
4.22, 1H), 3.87 (s, 1H), 4.11–4.20 (m, 2H), 4.44–4.49 (m, 1H),
4.72 (t, J = 5.90, 1H), 4.75–4.78 (m, 1H), 4.89 (d, J = 46.32, 2H),
6.05 (d, J = 5.84, 1H), 8.29 (s, 1H), 8.49 (s, 1H).
19F-NMR (380 MHz, D2O/H2O, ppm): d 2225.10.
HR-ESI-MS: [M+H]+ C23H38FN7O17P3S observed: 828.1280; cal-
culated: 828.1242.
Assay of FlK
The thioesterase activity of FlK was routinely assayed by monitoring
spectrophotometrically the increase in absorbance at 412 nm due to
the reaction of released CoASH with 5,50-dithiobis-2-nitrobenzoic
acid (DTNB) in a CARY 100 Bio UV-vis spectrophotometer (Varian)
by using a previously described method [27] with modification. All
assays were performed at 25ºC in a total volume of 0.5 ml in a spec-
trophotometer cuvette with a 1 cm light path containing the follow-
ing components (final concentrations): Tris-HCl (100 mM, pH 8.0),
fluoroacetyl-CoA (40, 30, 25, 20, 15, and 10 mM) or acetyl-CoA
(1000, 700, 300, 250, 200, 150, 100, and 70 mM), DTNB (0.5 mM),and purified FlK (5 ng for assays with fluoroacetyl-CoA as substrate
and 5–50 ng for acetyl-CoA experiments). Reactions without FlK or
substrates (fluoroacetyl-CoA or acetyl-CoA) were performed as con-
trols. Data points are the mean value of three replicates. The stan-
dard curve of CoASH (0–50 mM) was prepared by using commercially
available CoASH (Sigma) in Tris-HCl (100 mM, pH 8.0) in the pres-
ence of DTNB (0.5 mM). A Lineweaver-Burk plot was used to deter-
mine the Km and Vmax of FlK-catalyzed fluoroacetyl-CoA hydrolysis.
In addition, the formation of fluoroacetate from fluoroacetyl-CoA by
FlK was verified by 19F-NMR.
Fluoroacetyl-CoA: 19F-NMR (380 MHz, D2O/H2O/50 mM Tris-HCl
[pH 8.0], ppm): d 2224.88.
Fluoroacetate: 19F-NMR (380 MHz, D2O/H2O/50 mM Tris-HCl
[pH 8.0], ppm): d 2216.97.
DTNB-CoA: ESI-MS: [M+H]+ 965 (100), 767 (4), 583 (8), 483 (4),
458 (10), 437 (8).
Assay of FlI
A typical FlI reaction contained 100 mg FlI and either AdoHcy (1.0
mM) (forward reaction) or homocysteine (1.0 mM) and adenosine
(1.0 mM) (reverse reaction) in 100 ml Tris-HCl buffer (50 mM, pH
7.5). Control reactions were carried out in the absence of FlI or sub-
strate(s). The reaction mixture was incubated at 37ºC for 60 min and
quenched by the addition of chloroform (100 ml) and vortexed for 1
min. The protein precipitate was removed by centrifugation. The su-
pernatant was analyzed by LC-MS (ThermoFinnigan LCQ fitted with
an ESI source connected to an Agilent HP 1100 HPLC system). Fifty
to one hundred microliter samples were injected onto a Grom-Sil
ODS-4HE HPLC column (125 mm 3 2 mm, 2 mm; Alltech Grom
GmbH, Rottenburg-Hailfingen, Germany) and separated by gradient
elution. HPLC conditions: 100% A for 15 min, gradient to 100% B in
10 min, 100% B for 5 min; A: H2O 0.1% TFA, B: CH3CN 0.1% TFA; flow
rate 0.2 ml/min. The retention times and the MS spectra of adenosine
and S-adenosylhomocysteine were compared to authentic stan-
dards. The homocysteine released was derivatized with DTNB and
detected by LC-MS. Commercially available homocysteine (Sigma)
served as standard.
Adenosine: ESI-MS: [M+H]+ 268 (100), 160 (4), 136 (76); ESI-MS/
MS: 268 (8), 136 (100); retention time: 5.1 min.
DTNB-homocysteine: ESI-MS: [M+H]+ 333 (100); retention time:
21.9 min.
S-adenosylhomocysteine: ESI-MS: [M+H]+ 385 (100), 250 (30),
136 (44); ESI-MS/MS of 385: 250 (100), 136 (42); retention time:
4.8 min.
For kinetic studies of FlI activity, in 500 ml 50 mM Tris-HCl (pH 7.5)
buffer, 120 ng purified FlI was incubated at 30ºC with AdoHcy at con-
centrations of 120, 160, and 200 mM. A 100 ml aliquot of each reaction
was taken out after 2, 4, 6, 8, and 10 min incubation and vortexed
immediately with an equal volume of chloroform to precipitate the
enzyme. The reactions were analyzed by LC-MS as described
above. The abundance of adenosine formed was quantified based
on the area integration of the adenosine peak. The Km and Vmax
of FlI-catalyzed hydrolysis of AdoHcy was determined by a Line-
weaver-Burk plot. Authentic adenosine (Sigma) was used for the
standard curve.
Supplemental Data
Supplemental Data include Experimental Procedures and are avail-
able at http://www.chembiol.com/cgi/content/full/13/5/475/DC1/.
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